Blueshift Asset Management’s Everpure Inc P Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$753K Buy
+12,756
New +$864K 0.23% 113
2024
Q4
Sell
-6,057
Closed -$304K 484
2024
Q3
$304K Buy
+6,057
New +$342K 0.08% 275
2023
Q1
Sell
-8,540
Closed -$229K 437
2022
Q4
$229K Buy
+8,540
New +$248K 0.11% 277
2022
Q2
Sell
-42,762
Closed -$1.51M 948
2022
Q1
$1.51M Buy
+42,762
New +$1.24M 0.14% 191
2021
Q4
Sell
-53,630
Closed -$1.35M 1155
2021
Q3
$1.35M Sell
53,630
-72,698
-58% -$1.61M 0.08% 327
2021
Q2
$2.47M Buy
126,328
+100,564
+390% +$1.98M 0.14% 179
2021
Q1
$555K Buy
+25,764
New +$613K 0.06% 439
2020
Q4
Sell
-51,455
Closed -$792K 839
2020
Q3
$792K Buy
+51,455
New +$841K 0.11% 250
2019
Q3
Sell
-58,654
Closed -$896K 917
2019
Q2
$896K Buy
+58,654
New +$1.15M 0.12% 271

Other funds holding P

Blueshift Asset Management's P Position: Q1 2026 in Review

Blueshift Asset Management opened a new position in Everpure Inc (P) in Q1 2026: 12,756 shares worth $753K. The stake represents 0.23% of the portfolio and ranks #113 among its holdings. This is a return to the name: Blueshift Asset Management previously reported a position in P as recently as Q3 2024.

Blueshift Asset Management first reported a position in P in Q2 2019 and has held it in 9 quarters since. The position peaked at $2.47M in Q2 2021. 763 funds tracked by Wall St. Rank hold P as of Q1 2026.

  • Blueshift Asset Management held 12,756 shares of Everpure Inc worth $753K as of Q1 2026.
  • Everpure Inc was a new Blueshift Asset Management position in Q1 2026.
  • Everpure Inc made up 0.23% of Blueshift Asset Management's portfolio in Q1 2026, its #113 holding.
  • Blueshift Asset Management first reported a position in Everpure Inc in Q2 2019 and has held it in 9 quarters since.
  • Blueshift Asset Management's Everpure Inc position peaked at $2.47M in Q2 2021.
  • 763 funds tracked by Wall St. Rank held Everpure Inc as of Q1 2026.

Based on Blueshift Asset Management's 13F filing for Q1 2026, filed 14 May 2026.